Heavy Menstrual Bleeding (HMB) Market Outlook, Trends And Future Opportunities (2024-2031)

Heavy Menstrual Bleeding (HMB) Market, By Treatment Type (Medications, Surgical Interventions, Other Treatments), By Disease Type (Uterine Fibroids, Endometriosis, Adenomyosis, Hormonal Imbalances, Others), By Route of Administration (Oral, Parenteral, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Device Type (Endometrial Ablation Devices, Hysteroscopes, Resectoscopes, Others), By Technology (Radiofrequency Ablation, Cryoablation, Thermal Balloon Ablation, Hydrothermal Ablation, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.

Published On: May 2024
Author(s): Sagar Karlekar
Report ID: IDA155
Region: Global
Format: PDF/EXCEL

Press Release: Heavy Menstrual Bleeding (HMB) Market is Forecasted to Hit US$ 2.4 Bn By 2031 | CAGR 8.9%

Table Of Contents:

Chapter 1. Research Methodology and Scope
- Market Segmentation and Scope
- Regional Coverage
- Objectives
- Research Methodology
Chapter 2. Executive Summary
- Market Landscape
- Market Size & Forecast
- Competitive Landscape
Chapter 3. Heavy Menstrual Bleeding (HMB) Market: By Treatment Type Market Trends, Size, and Future Outlook
- By Treatment Type Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By Treatment Type Definitions, Technology Landscape
- By Treatment Type Market Drivers
  - Product Launches
  - Technology Launches
- By Treatment Type Market Restraints
Chapter 4. Heavy Menstrual Bleeding (HMB) Market: By Disease Type Market Trends, Size, and Future Outlook
- By Disease Type Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By Disease Type Definitions, Technology Landscape
- By Disease Type Market Drivers
  - Product Launches
  - Technology Launches
- By Disease Type Market Restraints
Chapter 5. Heavy Menstrual Bleeding (HMB) Market: By Route of Administration Market Trends, Size, and Future Outlook
- By Route of Administration Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By Route of Administration Definitions, Technology Landscape
- By Route of Administration Market Drivers
  - Product Launches
  - Technology Launches
- By Route of Administration Market Restraints
Chapter 6. Heavy Menstrual Bleeding (HMB) Market: By End-User Market Trends, Size, and Future Outlook
- By End-User Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By End-User Definitions, Technology Landscape
- By End-User Market Drivers
  - Product Launches
  - Technology Launches
- By End-User Market Restraints
Chapter 7. Heavy Menstrual Bleeding (HMB) Market: By Distribution Channel Market Trends, Size, and Future Outlook
- By Distribution Channel Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By Distribution Channel Definitions, Technology Landscape
- By Distribution Channel Market Drivers
  - Product Launches
  - Technology Launches
- By Distribution Channel Market Restraints
Chapter 8. Heavy Menstrual Bleeding (HMB) Market: By Device Type Market Trends, Size, and Future Outlook
- By Device Type Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By Device Type Definitions, Technology Landscape
- By Device Type Market Drivers
  - Product Launches
  - Technology Launches
- By Device Type Market Restraints
Chapter 9. Heavy Menstrual Bleeding (HMB) Market: By Technology Market Trends, Size, and Future Outlook
- By Technology Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By Technology Definitions, Technology Landscape
- By Technology Market Drivers
  - Product Launches
  - Technology Launches
- By Technology Market Restraints
Chapter 10. Heavy Menstrual Bleeding (HMB) Market: Regional Market Trends, Size, and Future Outlook
- North America
  - Trends, Market Size (US$), CAGR (%), and Future Outlook
  - Market Size (US$), CAGR (%), and Forecast (2021-2031)
  - Definitions, Technology Landscape
  - Market Drivers
    - Product Launches
    - Technology Launches
  - Market Restraints
  - Competitive Outlook
- Europe
  - Trends, Market Size (US$), CAGR (%), and Future Outlook
  - Market Size (US$), CAGR (%), and Forecast (2021-2031)
  - Definitions, Technology Landscape
  - Market Drivers
    - Product Launches
    - Technology Launches
  - Market Restraints
  - Competitive Outlook
- Asia Pacific
  - Trends, Market Size (US$), CAGR (%), and Future Outlook
  - Market Size (US$), CAGR (%), and Forecast (2021-2031)
  - Definitions, Technology Landscape
  - Market Drivers
    - Product Launches
    - Technology Launches
  - Market Restraints
  - Competitive Outlook
- Latin America
  - Trends, Market Size (US$), CAGR (%), and Future Outlook
  - Market Size (US$), CAGR (%), and Forecast (2021-2031)
  - Definitions, Technology Landscape
  - Market Drivers
    - Product Launches
    - Technology Launches
  - Market Restraints
  - Competitive Outlook
- Middle East, and Africa
  - Trends, Market Size (US$), CAGR (%), and Future Outlook
  - Market Size (US$), CAGR (%), and Forecast (2021-2031)
  - Definitions, Technology Landscape
  - Market Drivers
    - Product Launches
    - Technology Launches
  - Market Restraints
  - Competitive Outlook
Chapter 11. Heavy Menstrual Bleeding (HMB) Market: Competitive Landscape
- Bayer AG
  - Company Overview
  - Financial Outlook
  - Product Portfolio
  - Strategies
- Ferring Pharmaceuticals
  - Company Overview
  - Financial Outlook
  - Product Portfolio
  - Strategies
- Myovant Sciences
  - Company Overview
  - Financial Outlook
  - Product Portfolio
  - Strategies
- Allergan plc
  - Company Overview
  - Financial Outlook
  - Product Portfolio
  - Strategies
- Gedeon Richter Plc
  - Company Overview
  - Financial Outlook
  - Product Portfolio
  - Strategies
- Hologic, Inc.
  - Company Overview
  - Financial Outlook
  - Product Portfolio
  - Strategies
- Boston Scientific Corporation
  - Company Overview
  - Financial Outlook
  - Product Portfolio
  - Strategies
- Cooper Surgical, Inc.
  - Company Overview
  - Financial Outlook
  - Product Portfolio
  - Strategies
- Olympus Corporation
  - Company Overview
  - Financial Outlook
  - Product Portfolio
  - Strategies
- Karl Storz GmbH & Co. KG
  - Company Overview
  - Financial Outlook
  - Product Portfolio
  - Strategies
- Richard Wolf GmbH
  - Company Overview
  - Financial Outlook
  - Product Portfolio
  - Strategies
- Stryker Corporation
  - Company Overview
  - Financial Outlook
  - Product Portfolio
  - Strategies
- Medtronic plc
  - Company Overview
  - Financial Outlook
  - Product Portfolio
  - Strategies
- Johnson & Johnson
  - Company Overview
  - Financial Outlook
  - Product Portfolio
  - Strategies
- Merck & Co., Inc.
  - Company Overview
  - Financial Outlook
  - Product Portfolio
  - Strategies
- Pfizer Inc.
  - Company Overview
  - Financial Outlook
  - Product Portfolio
  - Strategies
- Novartis AG
  - Company Overview
  - Financial Outlook
  - Product Portfolio
  - Strategies
- AbbVie Inc.
  - Company Overview
  - Financial Outlook
  - Product Portfolio
  - Strategies
- GlaxoSmithKline plc
  - Company Overview
  - Financial Outlook
  - Product Portfolio
  - Strategies
- Sanofi S.A.
  - Company Overview
  - Financial Outlook
  - Product Portfolio
  - Strategies
Research Methodology
- Primary Research
- Secondary Research
- Assumptions
- IDataAcumen Analysis
- Paid Databases
Appendix
- About Us

Frequently Asked Questions

The current market size of the Heavy Menstrual Bleeding (HMB) industry is USD 1.2 billion.

Increasing prevalence of gynecological disorders, rising awareness about women's health, changing lifestyle and dietary habits, growing geriatric female population, technological advancements in medical devices, development of novel therapies, increasing healthcare expenditure, and strategic collaborations and partnerships.

High cost of treatments, lack of healthcare access, social stigma and cultural barriers, stringent regulatory environment, limited awareness in developing regions, side effects of treatments, and lack of reimbursement policies.

The leading component segment in the Heavy Menstrual Bleeding (HMB) Market is the medications segment, which includes hormonal contraceptives, NSAIDs, and antifibrinolytic agents for the treatment of HMB.

Bayer AG, Ferring Pharmaceuticals, Myovant Sciences, Allergan plc, Gedeon Richter Plc, Hologic, Inc., Boston Scientific Corporation, Cooper Surgical, Inc., Olympus Corporation, Karl Storz GmbH & Co. KG, Richard Wolf GmbH, Stryker Corporation, Medtronic plc, Johnson & Johnson, Merck & Co., Inc., Pfizer Inc., Novartis AG, AbbVie Inc., GlaxoSmithKline plc, and Sanofi S.A.

The North American region is expected to lead the Heavy Menstrual Bleeding (HMB) Market, with a market share of 38.2%. The global market size is projected to reach USD 2.4 billion by 2031, growing at a CAGR of 8.9% from 2024 to 2031.

Download FREE Sample Buy Now

Heavy Menstrual Bleeding (HMB) Market Outlook, Trends And Future Opportunities (2024-2031)

Heavy Menstrual Bleeding (HMB) Market Outlook, Trends And Future Opportunities (2024-2031)

Frequently Asked Questions

BUYING OPTIONS

Useful Links

Heavy Menstrual Bleeding (HMB) Market Outlook, Trends And Future Opportunities (2024-2031)

Heavy Menstrual Bleeding (HMB) Market Outlook, Trends And Future Opportunities (2024-2031)

Frequently Asked Questions

What is the current market size of the Heavy Menstrual Bleeding (HMB) industry?

What factors are contributing significantly to the growth of the Heavy Menstrual Bleeding (HMB) market?

What are the key factors hampering the growth of the Heavy Menstrual Bleeding (HMB) Market?

Which is the leading component segment in the Heavy Menstrual Bleeding (HMB) Market?

Which are the major players operating in the Heavy Menstrual Bleeding (HMB) Market?

What will be the CAGR and market size of the Heavy Menstrual Bleeding (HMB) Market?

What are the drivers of the Heavy Menstrual Bleeding (HMB) Market?

BUYING OPTIONS